Authors: Bajetta, E Bichisao, E Artale, S Celio, L Ferrari, L Di Bartolomeo, M Zilembo, N Stani, SC Buzzoni, R

Citation: E. Bajetta et al., New clinical trials for the treatment of neuroendocrine tumors, Q J NUCL M, 44(1), 2000, pp. 96-101

Authors: Bajetta, E Di Bartolomeo, M Stani, SC Artale, S Ricci, SB Bozzetti, F Mazzaferro, V Toffolatti, L Buzzoni, R

Citation: E. Bajetta et al., Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: Results of a feasibility study, INT J RAD O, 45(2), 1999, pp. 285-289

Authors: Di Bartolomeo, M Bajetta, E Buzzoni, R Bozzetti, F Artale, S Valvo, F

Citation: M. Di Bartolomeo et al., Integrated treatment with doxifluridine and radiotherapy in recurrent or primary unresectable rectal cancer. A feasibility study, TUMORI, 85(3), 1999, pp. 211-213

Authors: Bajetta, E Ferrari, L Martinetti, A Celio, L Procopio, G Artale, S Zilembo, N Di Bartolomeo, M Seregni, E Bombardieri, E

Citation: E. Bajetta et al., Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors, CANCER, 86(5), 1999, pp. 858-865